Aortic Stenosis Clinical Trial
Official title:
The Effects of High Spinal Anesthesia on Hemodynamics, Stress Response, Renal Function and Post-operative Pain Control in Patients Undergoing Aortic Valve Replacement for Aortic Stenosis
Verified date | July 2013 |
Source | University of Manitoba |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
This study is looking at the effects of high spinal anesthesia (also known as total spinal
anesthesia) combined with general anesthesia versus general anesthesia alone on the
following:
Stress response: Patients undergoing aortic valve replacement surgery have a large incision
and a complex operation where they must be placed on the heart-lung machine. The body reacts
to the heart-lung machine, increasing the stress response.
High spinal anesthesia using local anesthetics when combined with general anesthesia has
been shown to block some of the stress response to surgery and the response to the
heart-lung machine. This study will examine if blood levels of stress hormones and also
inflammatory mediators can be lowered with the use of high spinal anesthesia.
Heart function: High spinal anesthesia in combination with general anesthesia may help the
heart work better when there is a narrowed valve (aortic stenosis). The heart may also have
improved ability to pump blood with this anesthetic technique.
Lung function and post-operative pain control: After surgery, patients often have pain which
prevents them from taking deep breaths and coughing. This can lead to pneumonia. This study
will also examine if the post-operative pain relief provided by spinal morphine (given
together with the spinal anesthetic) can provide any better pain control following surgery.
By doing this, we want to see if patients can take bigger breaths after their surgery when
spinal morphine is used, and try to prevent the complications that occur if patients are not
able to breath deeply after surgery.
Status | Completed |
Enrollment | 14 |
Est. completion date | July 2013 |
Est. primary completion date | July 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Undergoing surgery for aortic valve replacement due to aortic stenosis with or without CABG. Exclusion Criteria: - INR > 1.4, PTT > 40 seconds - platelet count < 80, 000 per microlitre - local infection or deformity at the site of administration of the spinal anesthetic - raised intracranial pressure or evolving neurological deficit at the time of surgery |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | St. Boniface General Hospital | Winnipeg | Manitoba |
Lead Sponsor | Collaborator |
---|---|
University of Manitoba | Health Sciences Centre Foundation, Manitoba, St. Boniface General Hospital Research Centre |
Canada,
Jacobsohn E, Lee TW, Amadeo RJ, Syslak PH, Debrouwere RG, Bell D, Klock PA, Tymkew H, Avidan M; University of Manitoba Health Sciences Centre Cardiac Anesthesia Group. Low-dose intrathecal morphine does not delay early extubation after cardiac surgery. Can J Anaesth. 2005 Oct;52(8):848-57. — View Citation
Kowalewski R, MacAdams C, Froelich J, Neil S, Maitland A. Anesthesia supplemented with subarachnoid bupivacaine and morphine for coronary artery bypass surgery in a child with Kawasaki disease. J Cardiothorac Vasc Anesth. 1996 Feb;10(2):243-6. — View Citation
Lee TW, Grocott HP, Schwinn D, Jacobsohn E; Winnipeg High-Spinal Anesthesia Group. High spinal anesthesia for cardiac surgery: effects on beta-adrenergic receptor function, stress response, and hemodynamics. Anesthesiology. 2003 Feb;98(2):499-510. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stress response as measured by levels of circulating epinephrine, norepinephrine, and cortisol. | Multiple time points | No | |
Primary | Inflammatory response as measured by levels of circulating inflammatory mediators (e.g. interleukin-6, interleukin-8, interleukin-10, C-reactive protein, TNF-alpha). | Multiple time points | No | |
Primary | Blood glucose control (amount of insulin required to keep blood glucose 5-8 mmol/L). Renal function as measured by serum creatinine. | Multiple time points | No | |
Secondary | Vasopressor requirements to keep mean blood pressure between 60-80 mm Hg. | Multiple time points | No | |
Secondary | Left ventricular wall motion score index as measured by TTE and TEE. | Multiple time points | No | |
Secondary | Hemodynamics including cardiac output and cardiac index, heart rate, systemic arterial and pulmonary arterial blood pressures, central venous pressure, and systemic and pulmonary vascular resistance. | Multiple time points | No | |
Secondary | Time to extubation. | Time of extubation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Recruiting |
NCT06008080 -
Post-Market Clinical Follow Up Study With Navitor Valve
|
||
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Active, not recruiting |
NCT04815785 -
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
|
N/A | |
Terminated |
NCT02202434 -
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
Active, not recruiting |
NCT02903420 -
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
|
N/A | |
Completed |
NCT02629328 -
CardioCel Tri-leaflet Repair Study
|
N/A | |
Completed |
NCT02306226 -
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
|
||
Withdrawn |
NCT01648309 -
Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
|
N/A | |
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Completed |
NCT01422044 -
Risk Prediction in Aortic Stenosis
|
N/A | |
Withdrawn |
NCT00774657 -
Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography
|
N/A | |
Terminated |
NCT00535899 -
Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
|
N/A | |
Terminated |
NCT05070130 -
OpSens PRIME CLASS
|
||
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT04157920 -
Impact of Predilatation Between Self-expanding Valves
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT05893082 -
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
|
N/A |